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Abstract
We previously reported that a synthetic peptide with sequence identical to a CDR of a mouse monoclonal antibody specific
for difucosyl human blood group A exerted an immunomodulatory activity on murine macrophages. It was therapeutic
against systemic candidiasis without possessing direct candidacidal properties. Here we demonstrate that a selected
peptide, N10K, putatively deriving from the enzymatic cleavage of the constant region (Fc) of human IgG1, is able to induce
IL-6 secretion and pIkB-a activation. More importantly, it causes an up-regulation of Dectin-1 expression. This leads to an
increased activation of b-glucan-induced pSyk, CARD9 and pIkB-a, and an increase in the production of pro-inflammatory
cytokines such as IL-6, IL-12, IL-1b and TNF-a. The increased activation of this pathway coincides with an augmented
phagocytosis of non opsonized Candida albicans cells by monocytes. The findings suggest that some Fc-peptides,
potentially deriving from the proteolysis of immunoglobulins, may cause an unexpected immunoregulation in a way
reminiscent of innate immunity molecules.
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Introduction
Antibodies (Abs) consist of one or more copies of a tetrameric
unit, composed of two heavy (H) and two light (L) chains linked by
disulfide bonds [1]. H and L chains comprise variable (VH, VL)
and constant (CH, CL) regions, folded into functional domains,
involved in antigen (Ag) recognition and effector functions
respectively. Within the VH and VL domains, 3 hypervariable
complementarity determining regions (CDRs) can be identified,
and 4 relatively conserved framework regions [2,3]. In previous
studies we demonstrated that the synthetic decapeptide KP,
derived from VL of a recombinant antiidiotypic Ab (KT-scFv)
representing the internal image of a Pichia anomala killer toxin
(KT), may exert a microbicidal effect in vitro and in vivo against a
number of pathogenic microorganisms [4,5]. It displayed inhib-
itory activity against HIV-1 and influenza A virus, and proved to
modulate immune cell function by different mechanisms of action
[6,7,8].
Synthetic peptides, with sequences identical to CDRs of
monoclonal (m)Abs directed to unrelated Ags, showed different
antitumor, antiviral and antifungal activities in vitro and/or in vivo,
conceivably involving different mechanisms of action [9].
Moreover, we recently demonstrated that CDR H3 (VHCDR3)
of a mouse IgM mAb (MoA) specific for difucosyl of human blood
group A displayed a therapeutic effect against systemic candidiasis.
Given that it did not possess direct candidacidal properties, the
observed effect was ascribed completely to its immunomodulatory
activity [10].
We then reported that synthetic peptides, representative of
sequences included in the constant region (Fc) of the major classes
of human immunoglobulins (IgGs), and potentially deriving in
significant amounts from their enzymatic cleavage, had a
therapeutic effect on experimental mucosal and systemic candidi-
asis in mouse models [11]. The aim of this study was to evaluate
whether such synthetic Fc-peptides have immunomodulatory
activity and whether they can play a role in fighting fungal
infections.
Materials and Methods
Cell Culture Media
RPMI-1640 with L-glutamine and fetal calf serum (FCS) were
obtained from Gibco BRL (Paisley, Scotland). Penicillin-Strepto-
mycin solution was obtained from Sigma Aldrich (St. Louis, MO).
Complement was inactivated by heating FCS at 56uC for 30 min
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in a water bath. All reagents and media were negative for
endotoxin, as assessed by Limulus amebocyte lysate assay (QCL-
1000, BioWhittaker, Walkersville, MD).
Fc-peptides and Negative Control Peptide
Fc-peptides derived from the amino acid sequence analysis of
the different classes of Abs with a bioinformatic approach [11]
were chemically synthesized to be used for in vitro studies of
immunomodulatory activity. The Fc-peptides are listed in Table 1.
An irrelevant synthetic decapeptide (MSTAVSKCAT), previ-
ously proven to be devoid of either fungicidal or immunomodu-
latory activity in vitro, was synthesized to be used as a negative
control (NC) [4,7,10].
Fungal Strain
The origin and characteristics of the highly virulent Candida
albicans strain (CA-6) used in this study have previously been
described [12]. The culture was maintained by serial passages on
Sabouraud agar (BioMe´rieux, Lyon, France). The yeast cells were
harvested by suspending a single colony in saline, washed twice,
counted in a hemocytometer and adjusted to the desired
concentration. C. albicans cells were inactivated by heating at
60uC for 30 min (HI CA-6).
Cell Separation
Heparinised venous blood was obtained from healthy donors
and diluted with RPMI-1640 medium. The peripheral blood
mononuclear cells (PBMC) and neutrophils were obtained by
density gradient centrifugation on Ficoll-Hypaque. To obtain
monocytes, PBMC were washed twice in RPMI-1640 medium,
and incubated for 1 h at 37uC plus 5% CO2 in a culture flask.
After 1 h of incubation, adherent cells (monocytes) were recovered
as described by Monari C. et al. [13]. Ethics approval for this study
was obtained from ‘‘Comitato Etico Aziende Sanitarie’’ Umbria
(CEAS) Nu 1874/11. Written informed consent was obtained from
all subjects prior to sample collection.
Cytokine Production
Human neutrophils and monocytes (16107/ml) were incubated
for 18 h in RPMI-1640+10% FCS with heat inactivated
complement (complete medium) at 37uC plus 5% CO2 in the
presence/absence of LPS, NC or different Fc-peptides (H4L,
N10K, S8K, G7R and T11F, all 10 mg/ml). After incubation, the
supernatants were collected and tested for TNF-a and IL-6 levels
by specific ELISA assays (Biosource, Camarillo, CA). Monocytes
(56106/ml) were pre-incubated for 30 min in complete medium at
37uC plus 5% CO2 in the presence/absence of NC, N10K (both
10 mg/ml) or piceatannol (100 mM), and then stimulated for 18 h
in the presence/absence of HI CA-6 (E/T: 1/10), curdlan (25 mg/
ml) or zymosan (50 mg/ml). After incubation, the supernatants
were collected and tested for IL-6, IL-12p40, TNF-a, and IL-1b
levels by specific ELISA assays (Biosource). In selected experi-
ments, monocytes (56106/ml) were stimulated for 6 h, 18 h or
48 h in the presence/absence of zymosan (100 mg/ml), NC or
N10K (both 10 mg/ml). After incubation, the supernatants were
collected and tested for TNF-a and IL-1b levels by specific ELISA
assays (Biosource).
Cytokine titers were calculated by reference to standard curves,
constructed with known amounts of recombinant cytokines.
Flow Cytometry Analysis
Monocytes (16106/ml) were incubated for 30 min in complete
medium at 37uC plus 5% CO2 in the presence/absence of
zymosan (100 mg/ml), NC, N10K, H4L, S8K, G7R or T11F (all
10 mg/ml). In selected experiments, monocytes (16106/ml) were
pre-incubated for 30 min in complete medium at 37uC plus 5%
CO2 in the presence/absence of NC, N10K, H4L, S8K, G7R or
T11F (all 10 mg/ml) and subsequently incubated for 3 h in the
presence/absence of zymosan (50 mg/ml). After incubation, cells
were fixed with 4% formalin for 5 min at room temperature (RT),
washed twice with fluorescence buffer (FB), and labelled for
45 min on ice with R-Phycoerythrin (RPE) conjugated mAbs to
human Dectin-1 (5 ml/test; Mouse IgG2b isotype) (AbD Serotec,
Oxford, UK), TLR-2 (10 ml/106 cells; Mouse IgG1 isotype)
(USBiological, Massachusetts, MA) and TLR-4 (5 ml/test; Mouse
IgG2a,kappa isotype) (eBioscience, San Diego, CA). Then cells were
washed twice with FB and analyzed using a FACScan flow
cytometer (BD Biosciences, Franklin Lakes, NJ). To evaluate
phosphorylation of IkB-a, cells (16106/ml) were incubated for
30 min in complete medium at 37uC plus 5% CO2 in the
presence/absence of zymosan (100 mg/ml), NC or N10K (both
10 mg/ml). After incubation, cells were fixed with 1.5% formalin
for 5 min at RT, washed, incubated with absolute methanol
(500 ml/106 cells) for 10 min on ice to permeabilize cells, washed
twice and incubated with goat polyclonal Ab to phospho-IkB-a
(dilution 1:50, Santa Cruz Biotechnology Inc., Santa Cruz, CA)
followed by Cy3-labelled secondary Ab (dilution 1:100, Chemicon
Int., Temecula, CA) [14]. Data are expressed as mean of
fluorescence intensity (MFI) of labelled cells. Autofluorescence
was assessed using untreated cells. Control staining of cells with an
irrelevant Ab was used to obtain background fluorescence values.
Endocytosis of N10K
Monocytes (16106/ml) were pre-treated for 30 min in complete
medium at 37uC plus 5% CO2 in the presence/absence of
chlorpromazine (10 mg/ml) and subsequently treated for 30 min
in the presence/absence of biotin-labelled transferrin (b-transfer-
rin) (25 mg/ml), biotin-labelled NC (b-NC) or biotin-labelled
N10K (b-N10K) (both 10 mg/ml) [15]. After incubation, cells
were fixed with 4% formalin for 5 min at RT, permeabilized with
0.1% saponin, incubated for 20 min on ice with fluorescein
isothiocyanate (FITC)-conjugated mAb to biotin (1 ml/test; Mouse
IgG1 isotype) (Miltenyi Biotec, Bergish Gladbach, Germany), and
analyzed by a FACScan flow cytometer. Data are reported as
percentage of uptake.
Monocytes (26107/ml) were pre-treated for 30 min in complete
medium in the presence/absence of chlorpromazine (10 mg/ml)
and subsequently treated for 18 h in the presence/absence of
zymosan (100 mg/ml), LPS, NC or N10K (all 10 mg/ml). After
incubation, the supernatants were collected and tested for IL-6
level using specific ELISA assays. The cytokine titer was calculated
by reference to a standard curve, constructed with known amounts
of recombinant cytokine.
Table 1. Characteristics of Fc-peptides.
Fc-peptides Ig class Sequences
H4L IgG, IgM, IgA HEAL
N10K IgG1 NQVSLTCLVK
S8K IgG1 SLSLSPGK
G7R IgM GFPSVLR
T11F IgM TCRVDHRGLTF
doi:10.1371/journal.pone.0043972.t001
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Fluorescence Microscopy
Monocytes (16106/ml) were treated for 30 min in complete
medium at 37uC plus 5% CO2 in the presence/absence of b-
transferrin (25 mg/ml), b-NC or b-N10K (both 10 mg/ml). After
incubation, cells were fixed with 4% formalin for 5 min at RT,
permeabilized with 0.1% saponin, washed with 0.1% saponin,
incubated for 20 min on ice with FITC-conjugated mAb to biotin
(Miltenyi Biotec), washed with 0.1% saponin and resuspended
with FB. After staining, cells were collected by cytospin (26105/
200 ml) at 700 g for 7 min, reacted with 496-diamidino-2-
phenylindole (DAPI, Sigma) and subsequently examined under a
fluorescent light microscope (Carl Zeiss). An irrelevant Ab was
used to obtain background of fluorescence. Each condition was
studied in triplicate, and three images were taken for each sample.
The figures shown are representative of 5 separate experiments.
Confocal Microscopy Studies
Monocytes (16106/ml) were incubated for 30 min at 37uC plus
5% CO2 with b-N10K, washed three times with PBS and fixed
with 4% formalin for 10 min at RT. The cells were permeabilized
in 0.1% Triton X-100 for 10 min at RT and blocked with PBS
plus 2% BSA for 1 h at RT. Permeabilized cells were then
incubated for 1 h in the dark with streptavidin-fluorescein
isothiocyanate (S-FITC) (Invitrogen, Camarillo, CA) diluted
1:200 in PBS followed by propidium iodide (PI) (250 mg/ml)
(Sigma-Aldrich) staining for 5 min. Cells were washed three times
with PBS and 20 ml of mounting medium was added to each spot.
Monocytes were examined under a Zeiss LSM 510 Meta confocal
microscope with a 1006, 1.30 NA oil objective.
S-FITC and PI were excited with 488 nm argon and 543 nm
He-Ne laser lines, respectively. Acquisition was carried out in a
multitrack mode with the relevant beamsplitters; barrier filters
were 505–530 band pass and 560 long pass for the above signals,
respectively. A series of x-y sections was acquired with a z-step of
0.5 mm to cover the whole height of the samples.
Western Blot Analysis
PBMC (36106/ml) were pre-incubated for 30 min in complete
medium at 37uC plus 5% CO2 in the presence/absence of NC,
N10K (both 10 mg/ml) or piceatannol (100 mM) and subsequently
incubated for 5 min, 15 min or 30 min in the presence/absence of
zymosan (50 mg/ml). In selected experiments, monocytes (36106/
ml) were incubated for 30 min in complete medium at 37uC plus
5% CO2 in the presence/absence of zymosan (100 mg/ml), NC or
Figure 1. TNF-a and IL-6 production by monocytes and neutrophils stimulated with Fc-peptides. Monocytes (A) or neutrophils (B) (both
16107/ml) were cultured in the presence/absence (non stimulated, NS) of LPS, NC or different Fc-peptides (all 10 mg/ml) for 18 h. After incubation,
TNF-a and IL-6 levels were evaluated in culture supernatants using specific ELISA assays. *, P,0.05 (n = 5; treated vs untreated cells). Error bars denote
s.e.m.
doi:10.1371/journal.pone.0043972.g001
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N10K (both 10 mg/ml). After incubation, cells were washed and
lysed with mammalian protein extraction reagent (M-PER) in the
presence of protease and phosphatase inhibitors (all from Pierce,
Rockford, IL). The protein concentration was determined with a
BCA protein assay reagent kit (Pierce). The lysates (40 mg of each
sample) were separated by sodium dodecyl-sulfate-10% PAGE,
transferred to a nitrocellulose membrane (Pierce) for 1 h at 100 V
in a blotting system (Bio-Rad, Hercules, CA) for Western Blot
Figure 2. Endocytosis of N10K. Monocytes (16106/ml) were incubated for 30 min with b-transferrin (25 mg/ml), b-NC or b-N10K (both 10 mg/ml).
After incubation, permeabilized cells were reacted with FITC-labelled mAb to biotin, stained with DAPI and subsequently examined under fluorescent
light microscopy (A). In selected experiments, monocytes (16106/ml) were cultured with b-N10K (10 mg/ml). After incubation, permeabilized cells
were stained with S-FITC and PI and subsequently examined by confocal microscopy (B). The images show a single equatorial section of cells. In the
insets, one cell at large magnification is shown. Bar = 10 mm,. Inset bar = 5 mm.
doi:10.1371/journal.pone.0043972.g002
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analysis, and the membranes were incubated over-night with
rabbit polyclonal Abs to phospho-Syk (pSyk; dilution 1/300)
(Abcam), CARD9 (dilution 1/200) (Santa Cruz) and phospho-IkB-
a (pIkB-a; dilution 1/1000) (Cell Signalling Technology, Beverly,
MA) in blocking buffer. Detection was achieved using the
appropriated secondary Abs coupled to HRP, followed by use of
a Chemiluminescent kit (Bio-Rad). Immunoblotting with rabbit
polyclonal Abs to Syk, Actin and IkB-a (all with a dilution 1/200;
all from Santa Cruz) were used as internal loading controls to
ensure equivalent amounts of protein in each lane. Immunoreac-
tive bands were visualized and quantified by Chemidoc Instru-
Figure 3. Inhibition of N10K endocytosis. Monocytes (16106/ml) were pre-treated in the presence/absence of chlorpromazine (10 mg/ml) for
30 min and subsequently treated in the presence/absence (NS) of b-transferrin (25 mg/ml), b-NC or b-N10K (both 10 mg/ml) for 30 min. After
incubation, permeabilized cells were stained with FITC-labelled mAb to biotin and analyzed by FACScan flow cytometry. Data are reported as
percentage of uptake (A). *, P,0.05 (n = 5; chlorpromazine treated vs untreated cells). Error bars denote s.e.m. Monocytes (26107/ml) were pre-
treated in the presence/absence of chlorpromazine (10 mg/ml) for 30 min and subsequently treated in the presence/absence (NS) of zymosan
(100 mg/ml), LPS, NC or N10K (all 10 mg/ml) for 18 h. After incubation, IL-6 levels were evaluated in culture supernatants using specific ELISA assays.
(B) *, P,0.05 (n = 5; chlorpromazine treated vs untreated cells). Error bars denote s.e.m.
doi:10.1371/journal.pone.0043972.g003
Figure 4. Activation of IkB-a. Monocytes (16106/ml) were cultured in the presence/absence (NS) of zymosan (100 mg/ml), NC or N10K (both
10 mg/ml) for 30 min. After incubation, intracellular staining of cells was performed using phospho-IkB-a Ab followed by Cy3-labelled secondary Ab
and analyzed by FACScan flow cytometry. FACScan histograms represent MFI (A). Monocytes (36106/ml) were cultured as above described. After
incubation cell lysates were subjected to western blotting. Membranes were incubated with Abs to phospho-IkB-a and IkB-a. Western blotting bands
are shown; phospho-IkB-a was normalized against IkB-a (B). *, P,0.05 (n = 5; treated vs untreated cells). Error bars denote s.e.m.
doi:10.1371/journal.pone.0043972.g004
Immunoregulation by Antibody Peptides
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ment (Bio-Rad). A quantitative analysis of the region of interest
was performed as previously described [10].
FITC-labelling of C. albicans Cells
For use in the phagocytosis assay, HI CA-6 cells were harvested
and the concentration was adjusted to 16108/ml. Yeast cells were
labelled with FITC at 0.5 mg/ml in PBS at RT for 10 min as
previously described [16].
Determination of C. albicans Interaction with Monocytes
Monocytes (16107/ml) were incubated for 30 min in complete
medium at 37uC plus 5% CO2 in the presence/absence of NC,
N10K (both 10 mg/ml) or Cytochalasin D (30 mM) (Sigma) and
subsequently 100 ml of each cell suspension were incubated with
FITC-labelled yeast cells (100 ml; 16108/ml) for 30 min at 37uC
plus 5% CO2. Phagocytosis was stopped by adding 1 ml of ice cold
PBS to the suspension. Trypan blue (200 mg/ml) (Sigma) was
added and samples were incubated for 10 min to quench
fluorescence of non-internalized fungi. Unbound Trypan blue
was then removed by centrifugation and the percentage of
phagocytic cells was determined by flow cytometry [16,17].
Monocytes (16107/ml) were stimulated as above described. After
incubation, quantification of recognition and ingestion of C.
albicans cells was done using flow cytometry analysis as previously
described [18].
Trypan blue produces red fluorescence in cells upon binding.
This property of Trypan blue together with its ability to quench
the green fluorescence of fluorescein-labelled particles makes it
possible to simultaneously assess membrane-bound (CA) and
ingested (CI) C. albicans particles during phagocytosis by human
monocytes. Hence, the particles ingested by monocytes will
fluoresce green (FL1), while those attached to the cell membrane
will fluoresce bright red (FL3). A FSC threshold was set to gate out
debris. Monocytes and free C. albicans were discriminated by
combined measurements of FSC and SSC and gated in R1 and
R2 regions, respectively. The percentage distribution of monocyte
subsets was calculated from a dot plot analysis (FL1 vs FL3) of R1
gated events. The mean number of attached yeast particles per
monocytes (CA) was calculated by means of the formula below:
CA=Fmonocyte/FC,, where Fmonocyte is the mean red fluorescence in
monocytes (calculated considering the monocytes bearing red
fluorescent particles, which are the events in quadrant b and c) and
FC is the mean red fluorescence of free C. albicans particles. The
mean number of ingested yeasts per monocytes (CI) was assessed
as follows: CI=C–CA, where C is the mean number of monocyte-
associated yeasts (i.e. both attached and internalized particles),
calculated by subtracting the number of free C. albicans at the
Figure 5. Modulation of Dectin-1 expression by N10K. Monocytes (16106/ml) were incubated for 30 min in the presence/absence (NS) of
zymosan (100 mg/ml), NC, N10K, H4L, S8K, G7R or T11F (all 10 mg/ml) (A). In selected experiments, monocytes (16106/ml) were pre-treated for 30 min
in the presence/absence (NS) of NC, N10K, H4L, S8K, G7R or T11F (all 10 mg/ml) and subsequently stimulated for 3 h with zymosan (50 mg/ml) (B).
After incubation, cells were labelled with RPE mAb to Dectin-1 and analyzed by FACScan flow cytometry. MFI of labelled cells is shown as a histogram
or as a FACScan histogram (A and B). *, P,0.05 (n = 7; treated vs untreated cells). Error bars denote s.e.m.
doi:10.1371/journal.pone.0043972.g005
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selected incubation time from the number of free particles at t0
divided by the number of fluorescent phagocytosing monocytes
(calculated as the sum of the events in quadrants b, c and d). CA
and CI show the phagocytic index for each phagocytosing
monocyte.
Statistical Analysis
Data are reported as the mean 6 s.e.m. from triplicate samples
of 5–7 experiments and were evaluated using ANOVA. Post hoc
comparisons were done with Bonferroni’s test. A value of P,0.05
was considered significant.
Results
We have recently demonstrated the immunomodulatory effects
of a synthetic peptide, VHCDR3, whose sequence was derived
from the variable region of a mouse IgM mAb specific for
difucosyl of human blood group A [10].
This study evaluated the possibility that fragments selected
within the constant region of Abs, which could be obtained upon
digestion by physiological enzymes, i.e. trypsin and chymotrypsin,
display immunomodulatory activity.
First, the capacity of Fc-peptides to stimulate cytokine
production by innate immune cells such as neutrophils and
monocytes was evaluated. An irrelevant synthetic peptide was used
as a negative control (NC) in our experimental system [7,10]. LPS
was used as a positive control. Our results show that N10K
induced a significant up-regulation of IL-6 production, but not of
TNF-a production, by monocytes (Fig. 1A), while it was not able
to induce an increased production of either cytokine by
neutrophils (Fig. 1B). The other Fc-peptides and the NC peptide
did not affect cytokine production by either cell type.
Since N10K exerted a stronger effect on IL-6 production by
monocytes than all the other peptides, it was chosen for
subsequent experiments. It has been demonstrated that endocy-
tosis of light chains of Abs, excessively produced in multiple
myeloma by human proximal tubule cells, leads to production of
cytokines, such as IL-6, through activation of NF-kB [19]. In the
light of this evidence, we hypothesized that IL-6 production could
be mediated by the endocytosis process. Our results indicate that
N10K was efficiently internalized by monocytes after 30 min as
shown by conventional fluorescence (Fig. 2A) or confocal
microscopy (Fig. 2B) and cytofluorimetric (Fig. 3) analyses. In
particular, N10K shows a cytoplasmic distribution (Fig. 2B and
inset). N10K uptake was significantly inhibited by clathrin-
dependent endocytosis inhibitor chlorpromazine. Transferrin
was tested as an appropriate control of chlorpromazine activity
(Fig. 2A and 3) [15,20]. Indeed chlorpromazine pre-treatment
Figure 6. Dectin-1 signalling pathway activation. PBMC (36106/ml) were pre-treated for 30 min in the presence/absence (NS) of NC, N10K
(both 10 mg/ml) or piceatannol (Pic) (100 mM) and subsequently incubated for different times in the presence/absence of zymosan (50 mg/ml). After
incubation, cell lysates were subjected to western blotting. Membranes were incubated with Abs to pSyk, Syk, CARD9, Actin, pIkB-a and IkB-a.
Western blotting bands and protein normalizations are shown (A, B and C). *, P,0.05 (n = 5; N10K treated vs untreated cells). **, P,0.05 (n = 5; Pic
treated vs untreated cells). Error bars denote s.e.m.
doi:10.1371/journal.pone.0043972.g006
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Figure 7. Phagocytosis of C. albicans cells. Monocytes (16107/ml) were incubated for 30 min in the presence/absence of NC, N10K (both 10 mg/
ml) or Cytochalasin D (30 mM) and subsequently incubated with heat inactivated FITC-labelled yeast cells (HI CA-6) for 30 min. Percentage of
phagocytic cells was determined by flow cytometry (A). *, P,0.05 (n = 7; N10K treated vs untreated cells). Error bars denote s.e.m. Monocytes (16107/
ml) were treated as above described. Quantification of recognition and ingestion of yeast cells were determined by flow cytometry. Dot plots of the
distribution of green (FL1) and red (FL3) fluorescence are shown in panel B. Four distinct cell subsets are identified, which coincide with four types of
Immunoregulation by Antibody Peptides
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caused significant inhibition of IL-6 production induced by
zymosan and N10K treatment. Additionally, chlorpromazine
pre-treatment did not affect IL-6 production induced by LPS.
NC stimulation did not produce any effects (Fig. 2 and 3).
The activation of IkB-a phosphorylation after N10K treatment
was also evaluated in our experimental system. Results in Figure 4
show that 30 min after N10K treatment, there was a significant
up-regulation of IkB-a phosphorylation as indicated by flow
cytometry (A) and western blot (B) analyses. A significant induction
of p-IkB-a activation was observed after stimulation with zymosan.
Conversely, NC treatment did not show any effect.
Given that N10K can interact with innate immune cells and
induce IL-6 production, we next explored its ability to modulate
PRRs expression on monocytes. To this end, TLR-2, TLR-4 and
Dectin-1 expression were evaluated after peptide stimulation.
Our results show that there was a significant up-regulation of
Dectin-1 expression in monocytes after 30 min of stimulation with
N10K but not with NC or other peptides (Fig. 5A). Unlike Dectin-
1, TLR-2 and TLR-4 showed no modulation after N10K addition
(not shown).
It has been reported that zymosan, predominantly composed of
b-glucans, can induce Dectin-1 expression on monocytes
[21,22,23]. To explore the possibility that N10K increases
zymosan-induced Dectin-1 expression, cells were pre-treated for
30 min with peptides and then stimulated for 3 h with zymosan.
The results, reported in Figure 5B, show a marked up-regulation
of Dectin-1 expression following zymosan addition combined with
N10K. No effect was observed after pre-treatment with NC or
other peptides.
It is well known that the signal transduction pathway of Dectin-
1 occurs via Syk and CARD9 activation [17,24,25]. Thus, the
possibility that N10K treatment influences the activation of
proteins involved in zymosan-induced Dectin-1 signal pathway
was considered. To this purpose, PBMC were pre-treated with
N10K, NC, or piceatannol, which has been reported to selectively
block the Syk transduction pathway [17,26,27,28], and subse-
quently stimulated with zymosan for 5 min, 15 min or 30 min.
The results show that there was a high level of Syk phosphory-
lation after 5 min of zymosan stimulation in cells pre-treated with
N10K, the effect decreasing to negligible levels after 15 min and
30 min of zymosan stimulation (Fig. 6A). This effect was
correlated with an increase of the CARD9 protein level and
increased phosphorylation of IkB-a in cells pre-treated with N10K
and then stimulated with zymosan for 15 min and 30 min
respectively (Fig. 6B and C). The specificity of the stimulatory
activity of N10K was confirmed by the inability of the NC to
activate cells. Piceatannol inhibited pSyk, CARD9 and pIkBa
activation after 30 min of zymosan stimulation (Fig. 6).
Dectin-1 is a major receptor for b-glucans expressed on the cell
wall of fungi such as C. albicans [21,29]. Dectin-1 is the primary
receptor for phagocytosis of non opsonic zymosan particles and
fungi such as C. albicans by phagocytic cells [30,31,32,33,34]. As a
consequence, the possibility that N10K can affect the recognition
of C. albicans was evaluated. Phagocytosis of non opsonised HI CA-
6 by monocytes pre-treated for 30 min with N10K was evaluated
after 30 min of incubation. The results reported in Figure 7A show
that the pre-treatment of cells with N10K induced a significant
increase in the percentage of phagocytic cells. Moreover, N10K
was also able to increase the percentage of yeast particles adhered
or ingested by monocytes (Fig. 7B), and this effect was correlated
to the increase of the mean number of attached and ingested C.
albicans particles for each phagocytosing monocyte (phagocytic
index) (Fig. 7C). The specificity of N10K activity was confirmed by
the inability of the NC to increase C. albicans uptake by monocytes.
Cytochalasin D was used to block the phagocytic process [18].
Given that the engagement of Dectin-1 can regulate the
production of a variety of cytokines, we explored the possible
influence of N10K in the production of proinflammatory cytokines
in our experimental system. To this end, monocytes were pre-
treated with N10K for 30 min and then stimulated for 18 h in the
presence/absence of HI CA-6, zymosan, or curdlan, a Dectin-1
specific agonist and a linear polymer made up of b-1,3-glucan
[35]. The results show that N10K was able to induce a significant
production of IL-6, and when N10K was used in combination
with HI CA-6, curdlan and zymosan, a further increase in IL-6,
IL-12p40, TNF-a and IL-1b production was observed (Fig. 8A).
NC did not affect cytokine production. The treatment with
piceatannol caused a significant decrease of cytokine production
independently of the stimulus (Fig. 8A). Moreover, the kinetics of
TNF-a and IL-1b production by monocytes stimulated with
N10K show that N10K is also able to induce TNF-a and IL-1b
production after 6 h and 48 h, respectively (Fig. 8B).
Discussion
It has been demonstrated that, irrespective of the specificity of
the native Ab for a given Ag or the isotype, CDR-related or Fc-
peptides from murine or human Abs may display in vitro, ex vivo
and/or in vivo antimicrobial, antiviral, antitumor and immuno-
modulatory activity reminiscent of molecules of innate immunity
[4,5,9,10,11,36].
The aim of this work was to evaluate whether an Fc-peptide,
N10K, reputedly deriving from the enzymatic cleavage of the C
region of IgG1 Abs, can exert immunomodulatory activity on
human monocytes in vitro. The results of the research demonstrate
that N10K is able to induce: i) up-regulation of Dectin-1
expression, and further increase of Dectin-1 expression in
combination with microbial particles such as zymosan; ii)
activation of pIkB-a; iii) increased activation of b-glucan-induced
pSyk, CARD9 and pIkB-a; iv) production of IL-6, TNF-a and IL-
1b, and a further increase in the production of IL-6, IL-12p40, IL-
1b and TNF-a when used in combination with heat inactivated C.
albicans, curdlan and zymosan; vi) increased rate of phagocytosis of
non opsonized C. albicans cells. These data suggest that selected
short sequences representative of the Fc of Abs can influence the
immune response.
Recently we demonstrated that the Fc-peptide N10K displayed
therapeutic activity in a mouse model of systemic and vaginal
candidiasis, putatively owing to its demonstrated in vitro fungicidal
activity. This beneficial effect was evidenced as increase of survival
and as acceleration of fungal clearance from the vagina [11]. Here
we demonstrate that these important antimicrobial effects are
coupled with robust immunoregulatory activity. Indeed our results
demonstrate that N10K is rapidly internalized - and visible in the
cytoplasmatic compartment - by monocytes through endocytosis
involving clathrin-coated pits. It has previously been reported that
the nucleotide-binding oligomerization domain (NOD)-like recep-
tor (NLR) (nucleotide-binding domain leucine-rich repeat con-
monocyte-yeast interaction: quadrant a, no interaction; quadrant b, adherence; quadrant c, ingestion and adherence; quadrant d, ingestion (B). Panel
C shows the mean number of attached (CA) and ingested (CI) C. albicans particles per each phagocytosing monocyte calculated using data from plots
of panel B (see Materials and Methods section).
doi:10.1371/journal.pone.0043972.g007
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Figure 8. Proinflammatory cytokine production. Monocytes (56106/ml) were pre-treated in the presence/absence (NS) of NC, N10K (both
10 mg/ml) or piceatannol (Pic) (100 mM) for 30 min and subsequently incubated with heat inactivated C. albicans cells (HI CA-6, E/T:1/10), curdlan
(25 mg/ml) or zymosan (50 mg/ml) for 18 h. After incubation, cytokine levels were evaluated in culture supernatants using specific ELISA assays. (A) *,
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taining) family function as intracellular pattern-recognition recep-
tors that sense various molecules [37]. Indeed this intracellular
pathway which involves clathrin–dependent endocytosis leading to
activation of mitogen activated protein kinases and NFkB
activation [38] could be exploited by N10K for the direct
induction of cytokine production. Because the presence of IL-6
is required for Th17 generation [39], the possibility that this Fc-
peptide might favor Th17 activation arises.
Given that several chronic diseases such as rheumatoid arthritis
are characterized by massive presence of autoantibodies, one
could hypothesize that the synthetic peptides, potentially deriving
from enzymatic cleavage of autoantibodies, via induction of IL-6,
could help to trigger or maintain activation of Th17, which is
considered a key cell population mediating many chronic
inflammatory diseases [40].
It is worth noting that N10K is able by itself to induce NF-kB
activation, suggesting that it induces a state of activation related to
induction of IL-6 and an early induction of TNF-a production.
Moreover, a late induction of IL-1b could be related to the
increased early production of IL-6 and TNF-a. The specificity of
this activity could be due to important differences in the signal
pathway required for the induction of these cytokines [41,42]. The
regulatory activity of N10K is also manifested by a significant
increase of selected PRRs. Indeed, a significant enhancement of
Dectin-1 expression on N10K-treated monocytes was observed,
however, no modulation of other PRRs such as TLRs was
detected. Once again N10K selectively regulates some critical
molecules of the immune response. Moreover, we observed that
when N10K stimulation was associated with zymosan, which
specifically binds to Dectin-1, a further increase in Dectin-1
expression was manifested.
Signalling from Dectin-1 following ligand binding is mediated
through the cytoplasmic ITAM-like motif that becomes phos-
phorylated by Src family kinases, providing a docking site for Syk
[43]. Signalling downstream from Syk involves CARD9, which
assembles with BCL10 and MALT1 and has been identified as an
essential downstream adaptor linking Syk-coupled receptors to
NF-kB activation and, hence, cytokine production [21,43,44]. We
showed that N10K uptake by monocytes results in enhancement
of Syk, CARD9 and NF-kB activation induced by zymosan. These
molecular events are correlated with a more intense production of
proinflammatory cytokines when monocytes are pre-treated with
N10K and then stimulated with heat inactivated C. albicans,
curdlan or zymosan. Thus the importance of up-regulation of
Dectin-1 is demonstrated by the important biological effects
produced by N10K interaction with phagocytic cells. These results
strengthen the hypothesis that N10K can improve the immune
response to b-glucan Ags, therefore the anticandidal effect
previously described [11] might be related to a direct antimicrobial
effect associated with anti b-glucan immunostimulatory activity.
This is also confirmed by the increased binding and internalization
of heat inactivated C. albicans by N10K treated cells. Basically we
can assume that N10K-induced immunostimulatory activity is
closely related to the presence of b-glucan molecules, as a
consequence fungal cells which contain b-glucan are the major
end users of these effects.
Overall, our findings show that Fc-peptides potentially origi-
nating from Abs may, like CDR-related peptides, exert immuno-
modulatory activity, suggesting a new role for Abs in the immune
response.
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